Business
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP).
About this update from Sustainable Green Team, Ltd.
[{"type":"text","content":"\r\n\r\n \r\n \r\n New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)\r\n \r\n \r\n\r\n\r\nNew to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)\r\n\r\n\r\n\r\n\r\n\r\nCommercial sponsors are, Sustainable Green Team (SGTM) , Synergy CHC ($SNYR), DataVault AI ($DVLT),ACURX ($ACXP) ,($PETV) and Aeries Technology ($AERT) NEW YORK CITY, NEW YORK / ACCESS Newswire / December 20, 2025 / New to The Street, one of the longest-running and most widely distributed business television brands in the United States, will air a new nationally broadcast episode tonight at 6:30 PM ET on Bloomberg Television as sponsored programming.\r\n This week's broadcast features in-depth, executive-level interviews and company profiles with:\r\n \r\n NeOnc Technologies (NASDAQ: $NTHI)\r\n Metaterra Holdings Inc.\r\n CISO Global\r\n NRx Pharmaceuticals\r\n \r\n The episode delivers long-form conversations focused on business strategy, technology, clinical progress, and market positioning-filmed from iconic financial venues and designed to educate viewers without stock promotion.\r\n In addition to its national television reach, the broadcast is distributed across New to The Street's expansive digital ecosystem, including its YouTube channel with more than 4.2 million subscribers:https://www.youtube.com/@NewtotheStreetTV\r\n Featured Company Highlights\r\n NeOnc Technologies ($NTHI)\r\n NeOnc Technologies is a clinical-stage biopharmaceutical company advancing novel therapies for central nervous system cancers. Over the past 90 days, the company has reported updated clinical data demonstrating meaningful radiographic responses and extended survival outcomes in patients treated with its intranasal NEO100 therapy for recurrent high-grade astrocytoma. NeOnc has also completed enrollment in its pivotal Phase 2a clinical trial and strengthened its scientific advisory leadership as it prepares for future interim data readouts.\r\n Metaterra Holdings Inc.\r\n Metaterra Holdings continues to build momentum as an infrastructure-focused digital asset and real-world asset (RWA) platform. Recent announcements include the unveiling ...